About this trial

This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice.

Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy.

Eligibility criteria

Qualifiers

clinically significant mitral insufficiency

patient underwent screening for TMVI

echocardiography data at baseline (and after TMVI, E2E and surgery)

follow-up of at least 30 days

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 4 trial groups

Locations

43
Australia
St Vincent's Hospital Sydney Australia
Austria
Medical University of Vienna Vienna Austria
Canada
Québec Heart and Lung Institute (Laval University)G1V 4G5, QuébecQuebec, Canada
Toronto Heart Center Toronto Canada

Sponsors and collaborators

Universitätsklinikum Hamburg-Eppendorf

Lead sponsor

Montreal Heart Institute

Collaborator

University Hospital, Bordeaux

Collaborator